It is also most likely that the GLP-1 produced in the body is different from that produced in the brain
Injections are often made beneath the eyes, along the jawline, and in the cheeks, nose, temples, glabella, chin, and forehead
10.1007/s00726-012-1264-4 200
50% reduction in drug-related deaths 40% fewer overdoses 30% fewer emergency department visits 25% fewer hospitalizations In practical terms, that translates to seven fewer new SUD diagnoses and 12 fewer serious harm events per 1,000 GLP-1 users
This applies only to brand-name single-dose vials
This absence of evidence deserves careful consideration because researchers have specifically looked for carcinogenic effects and found none